Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-22-000691

Options or other derivatives

  • Director acquired 2,256 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ros Matthew · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,256 $5.15 $11,625 2,256 D
Loading xslF345X03/doc4.xml…